4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-24-000005
Chief Executive Officer gave up 3,728 shares (to pay taxes)
- Chief Executive Officer acquired 7,731 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-26 | Exercise or conversion : show line 1 in the form | +1,878 | 18,387 | D | ||
| 2024-02-26 | Shares withheld for taxes : show line 2 in the form | −872 | $8.16 | $7,116 | 17,515 | D |
| 2024-02-26 | Exercise or conversion : show line 3 in the form | +5,853 | 23,368 | D | ||
| 2024-02-26 | Shares withheld for taxes : show line 4 in the form | −2,856 | $8.16 | $23,305 | 20,512 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −1,878 | 0 | D |
| 2024-02-26 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −5,853 | 5,852 | D |
| 2024-02-28 | Grant or award : show line 7 in the form Common Stock Option | +69,733 | 69,733 | D |
| 2024-02-28 | Grant or award : show line 8 in the form Restricted Stock Unit | +55,895 | 55,895 | D |
Loading xslF345X05/wk-form4_1709158138.xml…